Cited by 94Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region

Open access
Asia Pacific Cohort Studies Collaboration·2007·Journal of Hypertension

Abstract

OBJECTIVE: To assess the association between systolic blood pressure (SBP) and cardiovascular diseases (CVD) among participants with and without diabetes from cohorts in the Asia-Pacific region. RESEARCH DESIGN AND METHODS: Hazards ratios and 95% confidence intervals (CI) for CVD were calculated from Cox models, stratified by sex and region and adjusted for age using individual participant data from 36 cohort studies. Repeat measurements of SBP were used to adjust for regression dilution bias. RESULTS: During follow-up, 7387 fatal or non-fatal cardiovascular endpoints were recorded among 368 307 participants (6.4% with diabetes). SBP was associated with coronary heart disease (CHD), ischaemic stroke and haemorrhagic stroke in a continuous log-linear fashion among individuals with diabetes, as well as those without diabetes. Overall, each 10 mmHg higher usual SBP was associated with 18% (95% CI: 9-27%) and 23% (19-26%) greater risk for CHD among those with and without diabetes, respectively. The corresponding values for ischaemic stroke were 29% (14-45%) and 43% (37-50%), and for haemorrhagic stroke, 56% (32-83%) and 74% (66-82%). The test for heterogeneity by diabetes status in each of these associations was not significant (P >or= 0.10). CONCLUSIONS: Systolic blood pressure is an important marker of risk of CVD in people with and without diabetes. A given reduction in systolic blood pressure is likely to have a similar relative effect on reducing the risk of a cardiovascular event, regardless of diabetes status.

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e3280dce59e

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The additional administration of EPA significantly decreased coronary events in Japanese patients who were taking statins for treating hypercholesterolemia complicated with impaired glucose metabolism.

    “The additional administration of EPA was also reported to significantly decrease coronary events in Japanese patients who were taking statins for treating hypercholesterolemia complicated with impaired glucose metabolism807).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Asia Pacific Cohort Studies Collaboration
Affiliations
The University of Sydney (AU)
Corresponding author
Asia Pacific Cohort Studies Collaboration
Venue
Journal of Hypertension
Published
2007-06
Volume
25
Issue
6
Pages
1205-1213
ISSN
0263-6352 (ISSN-L)
OpenAlex
W1565722632
Cited by
94
References
28
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 7 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 6 · 2013: 7 · 2012: 7
FWCI
6.31
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
  • Pfizer
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
systolic blood pressure, diabetes mellitus, cardiovascular risk, coronary artery disease, ischemic stroke, hemorrhagic stroke, hypertension, Asia-Pacific region, cohort studies, regression dilution bias
MeSH terms
Adult, Australia, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Humans, Risk Factors, Systole, Cohort Studies, Survival Analysis, Stroke, White People, Asian People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review